TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04726761

Intervention type: DIAGNOSTIC_TEST
Intervention: Ambulatory Blood Pressure Monitoring, frequent/non-frequent
Description: Patient will have a Spacelabs 90217 attached. This device can automatically measure the blood pressure over 24 hours. Patients will have their blood pressure measured first with a frequent interval, and then a non-frequent interval.

Intervention type: DIAGNOSTIC_TEST
Intervention: Ambulatory Blood Pressure Monitoring, non-frequent/frequent
Description: Patient will have a Spacelabs 90217 attached. This device can automatically measure the blood pressure over 24 hours. Patients will have their blood pressure measured first with a non-frequent interval, and then a frequent interval.
Study: NCT06564610

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transversus abdominis block
Description: The block will be performed by the surgeon by injecting local anesthetic at the beginning of surgery under the guidance of the laparoscope.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector spinae block
Description: The block will be performed by the anesthetist by injecting local anesthetic after induction of anesthesia under the guidance of the ultrasound.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bariatric surgery
Description: Laparoscopic bariatric procedure will be performed

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Description: Laparoscopic bariatric procedure will be performed

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endotracheal intubation
Description: An endotracheal tube will be inserted as a part of general anesthesia to all patients

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endotracheal intubation
Description: An endotracheal tube will be inserted as a part of general anesthesia to all patients

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: The patients will receive propofol for induction of anesthesia

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: The patients will receive propofol for induction of anesthesia
Study: NCT06182670

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gingival Former Abutment
Description: GFA is positioned on the sub-crestal implant during the surgery and it is no longer removed. This follows the one abutment one time concept and should prevent bone loss and transmucosal tunnel.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Subcrestal Implant
Description: Placement of the endosseous sub-crestal dental implant through dedicated drills with 35 Newton insertion torque. It is positioned 2 mm under the crestal bone.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Healing Abutment
Description: A healing abutment is positioned on crestal implant during surgery. It is removed at prosthetic finalization.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Prosthetic Crown
Description: A zirconia prosthetic crown finalizes the implant rehabilitation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prosthetic Crown
Description: A zirconia prosthetic crown finalizes the implant rehabilitation.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Crestal Implant
Description: Placement of the endosseous crestal implant through dedicated drills with 35 Newton insertion torque at level of the alveolar bone.
Study: NCT05443035

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Antimicrobial PDT and Papacarie Deproteinization
Description: Selective removal of carious tissue with curette + antimicrobial PDT (methylene blue 5 Evilux, Color index 52015, Fórmula \& Ação + red laser at 660 nm) + deproteinization of enamel with Papacárie DuoTM + restoration.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional caries treatment
Description: Selective removal of carious tissue with curette + restoration.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Antimicrobial PDT and 5% NaOCl Deproteinization
Description: Selective removal of carious tissue with curette + application of methylene blue and low-level laser (aPDT) + deproteinization of adjacent enamel with 5% NaOCl + restoration.
Study: NCT06112210

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HBOT group
Description: The HBOT will be performed in a Barox HBOT chamber (Yaklasim Makina San. Ve Tic. Ltd. Sti). Participants will be taken to the chamber immediately after the football match, where they will sit in individual chairs, and oxygen will be delivered through individual masks. The HBOT group will be exposed to 100% oxygen at 2.2 ATA (atmospheres absolute). Session will last 70 minutes.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: CON group
Description: The placebo protocols will be performed in a Barox HBOT chamber (Yaklasim Makina San. Ve Tic. Ltd. Sti). Participants will be taken to the chamber immediately after the football match, where they will sit in individual chairs, and oxygen will be delivered through individual masks. The CON group will be exposed to normobaric ambient pressure (1 ATA). The session will last 70 minutes.
Study: NCT05636540

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [18F]FluorThanatrace ([18F]FTT)
Description: A pre-treatment 18F-FluorThanatrace (\[18F\]FTT) positron emission tomography/computed tomography (PET/CT) scan will be done prior to surgery or systemic therapy.
Study: NCT06721871

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Powder for Oral Solution
Description: Matching Placebo Powder for Oral Solution

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Powder for Oral Solution
Description: Matching Placebo Powder for Oral Solution
Study: NCT05673369

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-387
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-387
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D484
Description: 1 Tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D484
Description: 1 Tablet
Study: NCT05417126

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Gene Therapy-vMCO-010
Description: The vMCO-010 is an adeno-associated virus serotype 2-based vector carried multi-characteristic opsin (MCO) gene expression cassette
Study: NCT05409807

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound guided smart glasses assisted
Description: Ultrasound guided smart glasses assisted interscalene nerve block

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound guided
Description: Ultrasound guided interscalene nerve block
Study: NCT05318807

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Assessment of level of readiness and need for personalised prehabilitation
Description: Patients asked to complete five validated questionnaires to assess their level of need and readiness:~1. Cancer Behaviour Inventory brief form - to measure self-efficacy for coping with cancer~2. Patient Activation Measure - to measure patient activation~3. Modified Godin Leisure Time Exercise Questionnaire - to monitor activity~4. Patient Generated Subjective Global Assessment - to identify malnutrition risk~5. Emotions thermometer - to detect emotional disorders and identify risk

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Formation of a personalised prehabilitation plan
Description: Prior to starting treatment, at week three and at week six, each patient will be invited to see a specialist dietitian for a one hour face-to-face personalised prehabilitation appointment to:~* Review the initial questionnaires to inform the personalised plan and goal setting~* Complete a further four questionnaires related to quality of life, diet and exercise~* Measure handgrip strength~* Assess functional capacity by completing the six minute walk test~A personalised plan is then agreed using SMART goals, taking into account the patient's priorities as indicated in their Patient Generated Index.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Daily diary
Description: Each patient will be asked to keep a daily diary to record their symptoms, appetite, mobility and mood throughout their treatment as well as their adherence to goals. This will provide an indication of the impact of symptoms.
Study: NCT06327477

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo IG-IMRT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resection
Description: Undergo surgical resection

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Spatially-fractionated Radiation Therapy
Description: Undergo P-SFRT
Study: NCT05137418

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccine,Inactivated
Description: The COVID-19 vaccine,inactivated was manufactured by Sinovac Research\& Development Co., Ltd..600SU Inactivated SARS-COV-2 virus in 0·5 mL of aluminium hydroxide solution per injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccine,Inactivated
Description: The COVID-19 vaccine,inactivated was manufactured by Sinovac Research\& Development Co., Ltd..600SU Inactivated SARS-COV-2 virus in 0·5 mL of aluminium hydroxide solution per injection
Study: NCT05932927

Intervention type: BIOLOGICAL
Intervention: Proteomic sequencing
Description: Proteomic sequencing, bioinformatics analysis，find abnormal indicators between two groups

Intervention type: BIOLOGICAL
Intervention: Proteomic sequencing
Description: Proteomic sequencing, bioinformatics analysis，find abnormal indicators between two groups
Study: NCT06173986

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1inhibitor
Description: PD-1 inhibitor, Q3W, until disease progression or unacceptable toxicity or treatment reaches 1 year

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel + cisplatin
Description: Induction phase: nab-paclitaxel + cisplatin, Q3W × 2 cycles; Concurrent ICRT phase: nab-paclitaxel + cisplatin, QW × 5 cycles

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Primary tumor and metastatic lymph nodes, DT:45-50Gy/25fx, starting within 4 weeks following the completion of the last induction immunochemotherapy cycle
Study: NCT06539039

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: non surgical periodontal therapy
Description: participants received full mouth one stage debridement using hand instruments and use of universal curette for sub gingival debridement and ultrasonic scalers through use of supragingival and subgingival ultrasonic tips

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: non surgical periodontal therapy
Description: participants received full mouth one stage debridement using hand instruments and use of universal curette for sub gingival debridement and ultrasonic scalers through use of supragingival and subgingival ultrasonic tips

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: non surgical periodontal therapy
Description: participants received full mouth one stage debridement using hand instruments and use of universal curette for sub gingival debridement and ultrasonic scalers through use of supragingival and subgingival ultrasonic tips
Study: NCT05267184

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endovascular treatment of the middle meningeal artery
Description: The middle meningeal artery on the same side(s) as the chronic subdural hematoma is embolized with liquid embolic agents.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard neurosurgical hematoma evacuation
Description: Standard neurosurgical evacuation of chronic subdural hematoma through burr-hole or mini craniotomy and postoperative subdural or subgaleal drainage.
Study: NCT05033379

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control
Description: Importance of sleep

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resilience coaching
Description: Arena Strive
Study: NCT06280027

Intervention type: OTHER
Intervention: survey
Description: An online survey was generated to quantitatively evaluate the level of esthetic perception.

Intervention type: OTHER
Intervention: survey
Description: An online survey was generated to quantitatively evaluate the level of esthetic perception.
Study: NCT06122272

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Test Formula
Description: The duration of the study for each subject from enrolment to final visit, is 12 months. Test Formula will be provided during this 12 month.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Formula
Description: The duration of the study for each subject from enrolment to final visit, is 12 months. Control Formula will be provided during this 12 month.
Study: NCT06515717

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ketone ester
Description: oral supplement

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: dextrose (placebo)
Description: oral supplement calorie and taste matched to ketone supplement
Study: NCT05628766

Intervention type: OTHER
Intervention: complete blood count
Description: Thiol/disulphide levels in the blood will be checked by taking complete blood count

Intervention type: OTHER
Intervention: complete blood count
Description: Thiol/disulphide levels in the blood will be checked by taking complete blood count
Study: NCT05244174

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pancreatic stent
Description: Insertion of a pancreatic stent during ERCP to improve pancreatic secretion

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pancreatic stent
Description: Insertion of a pancreatic stent during ERCP to improve pancreatic secretion
Study: NCT05614479

Intervention type: OTHER
Group type: OTHER
Intervention: GATEKEEPER intervention
Description: Agents will identify candidates in their areas of work (e.g., associations of elderly people).~Training sessions will be held for healthcare professionals and community agents.~Dissemination of materials, resources, and channels to contact and inform candidates to invite them to participate in the study. Recruitment procedures posters, leaflets, videos, newsletters, or appointments will be used.~Candidates interested and accepted will download the application on their mobile devices and will surf on the app which pretends to promote healthy aging. Users will provide some data and complete questionnaires (available in the application) for the baseline and final assessment.~Professionals will visualize how and how much participants are interacting by using the MAHA dashboard.
Study: NCT06122649

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: apremilast
Description: Oral tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: apremilast
Description: Oral tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral tablet
Study: NCT05323409

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: OPTIMISE
Description: OPTIMISE is a multilevel intervention that seeks to improve patient activation for comorbidity self-management during cancer treatment and coordination of care between oncologists and primary care physicians from point of diagnosis through the first year of post-treatment survivorship.
Study: NCT04739852

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fasting
Description: Patients undergo a 5-10 day fasting period with a dietary energy supply 350-400kcal per day with fruit and vegetable juices or, if not feasible, an established fasting-mimicking diet of 600-800 kcal according to Longo et al.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fasting
Description: Patients undergo a 5-10 day fasting period with a dietary energy supply 350-400kcal per day with fruit and vegetable juices or, if not feasible, an established fasting-mimicking diet of 600-800 kcal according to Longo et al.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fasting
Description: Patients undergo a 5-10 day fasting period with a dietary energy supply 350-400kcal per day with fruit and vegetable juices or, if not feasible, an established fasting-mimicking diet of 600-800 kcal according to Longo et al.
Study: NCT06496828

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biologically-oriented preparation technique
Description: The preparation will be made according to the new principles of biologically oriented technique to receive monolithic and bi-layered all-ceramic crowns.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional method of preparation
Description: Teeth prepared with shoulder margins to receive monolithic and bi-layered all-ceramic crowns
Study: NCT05840601

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pointdexter
Description: Commercially available prosthetic hand modified with the investigational Pointdexter finger in place of the usual index finger.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Comparator
Description: Unmodified commercially available prosthetic hand.
Study: NCT06153979

Intervention type: BIOLOGICAL
Intervention: Verorab
Description: Participants in each group will receive rabies vaccination (standard 3-dose series given as PrEP), with the first dose randomized to either Week 8 or Week 47 after enrollment.

Intervention type: BIOLOGICAL
Intervention: Verorab
Description: Participants in each group will receive rabies vaccination (standard 3-dose series given as PrEP), with the first dose randomized to either Week 8 or Week 47 after enrollment.
Study: NCT05966259

Intervention type: OTHER
Group type: OTHER
Intervention: Intervention Group- Intensive Multilevel Intervention
Description: intensive multilevel intervention, with a minimum of 26 contact hours, for a period of 5 months. The children will be re-evaluated in the eighth month (three months after intervention) and in the eleventh month (six months after intervention). The monthly activities were composed of four weekly contacts: Individual Attendance, Food and Nutrition Education (at home), Group Food and Nutrition Education in the basic health unit and Telephone monitoring. There will be five monthly themes: food, physical activity, sedentary behavior, sleep, and mental health.

Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: The children in the Control Group were followed in a similar way, observing the activities so that they did not exceed 26 hours of contact, during the 5 months.
Study: NCT06495125

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avutometinib
Description: Given PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Defactinib
Description: Given PO

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET
Study: NCT06540612

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: Aerobic exercise is a set of physical activities that work large muscle groups continuously and rhythmically.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity counseling
Description: Physical activity counselling is a service that provides personalized guidance and support to help individuals adopt a healthy lifestyle.
Study: NCT03601806

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Given PO
Study: NCT05802979

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adjuvants, Anesthesia
Description: testing the effect of adding ketamine versus neostigmine to the analgesic efficacy of serratus anterior plane block in modified radical mastectomy surgeries

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adjuvants, Anesthesia
Description: testing the effect of adding ketamine versus neostigmine to the analgesic efficacy of serratus anterior plane block in modified radical mastectomy surgeries

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Adjuvants, Anesthesia
Description: testing the effect of adding ketamine versus neostigmine to the analgesic efficacy of serratus anterior plane block in modified radical mastectomy surgeries
Study: NCT05495360

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplement
Description: twice daily serving of the study product
Study: NCT05243966

Intervention type: DEVICE
Intervention: Myriad Matrix™ and Myriad Morcells™
Description: Ovine forestomach matrix sheet graft and morselized extracellular matrix
Study: NCT05785026

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Menthol inhalation
Description: 300 milligrams of L-menthol will be deposited on to a cellulose swab and secured inside the lower portion of a sealed facemask.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Menthol inhalation
Description: 300 milligrams of L-menthol will be deposited on to a cellulose swab and secured inside the lower portion of a sealed facemask.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Menthol inhalation
Description: 300 milligrams of L-menthol will be deposited on to a cellulose swab and secured inside the lower portion of a sealed facemask.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Menthol inhalation
Description: 300 milligrams of L-menthol will be deposited on to a cellulose swab and secured inside the lower portion of a sealed facemask.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Strawberry scent
Description: 600 microliters of 100% natural strawberry flavoring will be deposited onto on to a cellulose swab and secured inside the lower portion of a sealed facemask.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Strawberry scent
Description: 600 microliters of 100% natural strawberry flavoring will be deposited onto on to a cellulose swab and secured inside the lower portion of a sealed facemask.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Strawberry scent
Description: 600 microliters of 100% natural strawberry flavoring will be deposited onto on to a cellulose swab and secured inside the lower portion of a sealed facemask.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Strawberry scent
Description: 600 microliters of 100% natural strawberry flavoring will be deposited onto on to a cellulose swab and secured inside the lower portion of a sealed facemask.